Skip to content

Polaryx Therapeutics, Inc. PLYX Other accrued liabilities

Other accrued liabilities at other companies

Rockwell Automation logo
Rockwell AutomationROK
$68M-23.6%
Cardinal Health logo
Cardinal HealthCAH
$3.48B+5.4%
Republic Services logo
Republic ServicesRSG
$1.24B+9.1%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$12.62B-23.6%
Wabtec logo
WabtecWAB
$792M+24.7%
UnitedHealth Group logo
UnitedHealth GroupUNH
$25.94B-12.0%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$115.64M

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's other accrued liabilities?
Polaryx Therapeutics, Inc. (PLYX) reported other accrued liabilities of $21K in Q4 2025.